Anavex Life Sciences Corp (AVXL)

[stealthways]

Data is not the only important information that goes into pricing a bio stock...The price (theoretically) represents ALL known information that indicates the probability of success with a given market size and derived cash flow.... Clearly, having patients respond to a drug in trials with improvement news, of any kind, reflects positively on the probability of success of a given drug, and this (with manipulation absent) has a proportional positive impact on the share price... This is basic knowledge in financial analysis and so am surprised to hear Closetinvestor repeat this logic over and over again today...